Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) › Operating Cash FlowCordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2021: -$365.4K2022: -$321.4K2023: $359.7K2024: $312.0K2025: -$35.8K-$35.8K2021Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$35.8K-111.5%2024$312.0K-13.3%2023$359.7K+211.9%2022-$321.4K+12.0%2021-$365.4K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share